Dear Editor:

Dr. Lotan\'s comments regarding our cost analysis of implementing a robotic prostatectomy program are well taken. With regard to the added costs of instruments, the figure of \$200 per case was \$200 above the cost per case of laparoscopy instruments at our center. The absolute cost of the instruments per case is, as Dr. Lotan sites, roughly \$1000. Our figure underestimates the difference in cost between the laparoscopic and robotic approaches, as it was derived from institution-specific data and is subject to local variation; however, the \$400,000+ annual cost of the robot and service contract remain the bulk of additional cost at all but the highest volume centers.

Secondly, with regards to Medicare reimbursement for this procedure, the average age in the Henry Ford Hospital experience is 60.2 years for patients undergoing robotic-assisted radical prostatectomy.^[@B1]^ Certainly, a center operating on a large number of Medicare beneficiaries stands to decrease its income relative to a center with fewer beneficiaries, but in this large series the average age is below the minimum for Medicare.

The clear relationship between volume and income with this procedure is a critical factor for any hospital seeking the development of a robotics program and the purchase of a robot. In our estimation, the caseload a center can expect is the critical factor in the decision to purchase a surgical robot, as it only pays for itself if it is utilized, in the same manner as an airplane. Other factors, such as attracting other patients to a center, recruitment of physicians and merely "keeping up," are important, but these effects are less easily discerned than the relationship between a large surgical caseload offsetting the expense of the robot.

Our paper was meant to temper the enthusiasm for this technology at low-volume centers, where the addition of robotics to the array of services of such centers may lead to financial harm, and prevent healthcare dollars from being more appropriately allocated.
